Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
October 14, 2026 CD derivatives / Other industrial use

Impact of Threading State on the Mechanics of γ-Cyclodextrin–Pyrene Gels

Researchers from the United States developed γCD-pyrene gels with different network architectures by controlling whether the CD-based crosslinkers were singly

Continue reading

October 9, 2026 Non-pharma applications / Pharma applications

Over 70,000 hits in Scopus for “cyclodextrin” keyword

Although discovered over 130 years ago, cyclodextrin research continues to flourish, as evidenced by data from Elsevier’s Scopus database. The

Continue reading

October 8, 2026 CD as API / CD derivatives / Pharma applications

Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded

The global, double-blind, placebo-controled Phase 3 TransportNPC™ study (CTD-TCNPC-301) enroled 94 patients with NPC, ranging in age from 3 to

Continue reading

July 25, 2018 Pharma applications / Supramolecular systems

Nanoaggregation on command

ScienceDaily reported on the effect of cyclodextrins as parts of synthetic receptors on the aggregation of proteins, recently published by

Continue reading

July 25, 2018 CD as API / Events / Pharma applications

Annual National Niemann Pick Disease Foundation Conference

Among several lectures useful for the families with member(s) suffering in rare diseases the ongoing clinical trials for NPC patients

Continue reading

Posts pagination

«Previous Posts 1 … 207 208 209

Recent Posts

  • Impact of Threading State on the Mechanics of γ-Cyclodextrin–Pyrene Gels
  • New Trends in Cyclodextrins Technology for Pharmaceutical
  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
  • Over 70,000 hits in Scopus for “cyclodextrin” keyword
  • Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (359)
  • CD derivatives (438)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (821)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (237)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (421)
  • Other industrial use (114)
  • Pharma applications (1,227)
  • Supramolecular systems (44)
  • Uncategorized (170)

Top Posts

  • Impact of Threading State on the Mechanics of γ-Cyclodextrin–Pyrene Gels
  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
  • HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
  • Coatings of Cyclodextrin/Citric-Acid Biopolymer as Drug Delivery Systems: A Review
  • Cyclodextrin science helps dishes sparkle
  • Novel polyrotaxane for Niemann Pick disease type C treatment
  • Eco-Friendly Nanoantibiotics: A New Approach to Combat Resistance
  • Trans sodium crocetinate/cyclodextrin to increase diffusion of oxygen
  • Cyclodextrin-based nanoparticles for pharmaceutical applications: a review
  • Hyaluronic acid-cyclodextrin conjugate encapsulating paeonol for treatment of atopic dermatitis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...